A detailed history of Ballentine Partners, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Ballentine Partners, LLC holds 8,572 shares of BAX stock, worth $308,506. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,572
Previous 8,919 3.89%
Holding current value
$308,506
Previous $298,000 9.06%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$32.85 - $40.26 $11,398 - $13,970
-347 Reduced 3.89%
8,572 $325,000
Q2 2024

Aug 06, 2024

SELL
$32.87 - $43.55 $4,766 - $6,314
-145 Reduced 1.6%
8,919 $298,000
Q1 2024

Apr 11, 2024

BUY
$37.88 - $43.77 $25,190 - $29,107
665 Added 7.92%
9,064 $387,000
Q4 2023

Jan 23, 2024

BUY
$31.71 - $38.95 $60,629 - $74,472
1,912 Added 29.47%
8,399 $324,000
Q3 2023

Oct 19, 2023

SELL
$37.32 - $49.29 $114,497 - $151,221
-3,068 Reduced 32.11%
6,487 $244,000
Q2 2023

Jul 26, 2023

BUY
$39.98 - $47.68 $93,713 - $111,761
2,344 Added 32.51%
9,555 $435,000
Q1 2023

Apr 27, 2023

BUY
$37.58 - $52.57 $73,281 - $102,511
1,950 Added 37.07%
7,211 $292,000
Q4 2022

Jan 27, 2023

SELL
$49.7 - $57.71 $61,628 - $71,560
-1,240 Reduced 19.07%
5,261 $0
Q3 2022

Oct 26, 2022

BUY
$53.86 - $66.8 $49,497 - $61,389
919 Added 16.46%
6,501 $350,000
Q2 2022

Aug 09, 2022

SELL
$63.83 - $80.0 $21,191 - $26,560
-332 Reduced 5.61%
5,582 $359,000
Q1 2022

May 05, 2022

BUY
$76.85 - $89.45 $5,072 - $5,903
66 Added 1.13%
5,914 $459,000
Q4 2021

Feb 14, 2022

BUY
$74.57 - $87.19 $8,202 - $9,590
110 Added 1.92%
5,848 $502,000
Q3 2021

Oct 27, 2021

SELL
$73.77 - $83.61 $5,532 - $6,270
-75 Reduced 1.29%
5,738 $462,000
Q2 2021

Aug 12, 2021

BUY
$80.5 - $88.01 $10,223 - $11,177
127 Added 2.23%
5,813 $468,000
Q1 2021

May 11, 2021

SELL
$76.38 - $86.03 $60,111 - $67,705
-787 Reduced 12.16%
5,686 $480,000
Q4 2020

Jan 25, 2021

SELL
$75.39 - $82.36 $58,954 - $64,405
-782 Reduced 10.78%
6,473 $520,000
Q3 2020

Oct 22, 2020

SELL
$78.33 - $90.73 $29,295 - $33,933
-374 Reduced 4.9%
7,255 $583,000
Q2 2020

Jul 31, 2020

BUY
$78.66 - $94.14 $2,045 - $2,447
26 Added 0.34%
7,629 $657,000
Q1 2020

Apr 23, 2020

BUY
$71.57 - $93.3 $36,429 - $47,489
509 Added 7.18%
7,603 $618,000
Q4 2019

Jan 22, 2020

SELL
$76.7 - $88.45 $4,065 - $4,687
-53 Reduced 0.74%
7,094 $593,000
Q3 2019

Oct 21, 2019

BUY
$81.4 - $89.78 $19,698 - $21,726
242 Added 3.5%
7,147 $625,000
Q2 2019

Jul 25, 2019

BUY
$73.44 - $82.41 $38,482 - $43,182
524 Added 8.21%
6,905 $565,000
Q1 2019

May 09, 2019

SELL
$64.48 - $81.31 $9,349 - $11,789
-145 Reduced 2.22%
6,381 $519,000
Q4 2018

Feb 04, 2019

SELL
$61.45 - $77.8 $23,842 - $30,186
-388 Reduced 5.61%
6,526 $429,000
Q3 2018

Oct 30, 2018

SELL
$70.71 - $77.75 $9,192 - $10,107
-130 Reduced 1.85%
6,914 $533,000
Q2 2018

Jul 19, 2018

BUY
$63.43 - $75.41 $231,773 - $275,548
3,654 Added 107.79%
7,044 $520,000
Q1 2018

Apr 26, 2018

SELL
$62.56 - $72.26 $24,961 - $28,831
-399 Reduced 10.53%
3,390 $220,000
Q4 2017

Feb 02, 2018

BUY
$61.45 - $66.05 $737 - $792
12 Added 0.32%
3,789 $245,000
Q3 2017

Nov 06, 2017

BUY
$59.5 - $64.61 $224,731 - $244,031
3,777
3,777 $236,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $18.1B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Ballentine Partners, LLC Portfolio

Follow Ballentine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.